These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 580099)

  • 1. Bone marrow necrosis during chemotherapy for lymphoma.
    Mason BA; Klug PP; Cohen P
    JAMA; 1978 Mar; 239(12):1158. PubMed ID: 580099
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic progress and iatrogenic problems in malignant hemopathies].
    Geib KR; Papazian R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(4):343-9. PubMed ID: 22916
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone marrow necrosis associated with the use of imatinib mesylate in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Matsue K; Takeuchi M; Koseki M; Uryu H
    Ann Hematol; 2006 Aug; 85(8):542-4. PubMed ID: 16570152
    [No Abstract]   [Full Text] [Related]  

  • 4. Unusual reaction to Rituximab with intra-vascular hemolysis, rhabdomyolysis, renal failure and bone marrow necrosis.
    Ramamoorthy SK; Marangolo M; Durrant E; Akima S; Gottlieb DJ
    Leuk Lymphoma; 2006 Apr; 47(4):747-50. PubMed ID: 16690535
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapy of advanced lymphocytic lymphoma a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy.
    Canellos GP; DeVita VT; Young RC; Chabner BA; Schein PS; Johnson RE
    Br J Cancer Suppl; 1975 Mar; 2():474-80. PubMed ID: 1101933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Side effects of antineoplastic agents used in combination with surgical operations, with reference to bone marrow disorders].
    Akagi M; Zaitsu S; Anzai S; Kiyomoto A; Mori K
    Gan No Rinsho; 1966 Oct; 12(10):628-34. PubMed ID: 6009336
    [No Abstract]   [Full Text] [Related]  

  • 7. Early leukemic recurrence of non-Hodgkin lymphoma after high-dose anti-neoplastic therapy with autologous marrow rescue.
    Vaughan WP; Weisenburger DD; Sanger W; Gale RP; Armitage JO
    Bone Marrow Transplant; 1987 Apr; 1(4):373-8. PubMed ID: 3332145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
    Collins-Burow B; Santos ES
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):257-73. PubMed ID: 17338647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated tuberculosis, bone marrow necrosis and lymphoma: a case report.
    Staples WG; Gétaz EP; Botha D
    S Afr Med J; 1977 Oct; 52(17):680-3. PubMed ID: 579679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow necrosis secondary to imatinib usage, mimicking spinal metastasis on magnetic resonance imaging and FDG-PET/CT.
    Aras Y; Akcakaya MO; Unal SN; Bilgic B; Unal OF
    J Neurosurg Spine; 2012 Jan; 16(1):57-60. PubMed ID: 22017257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of androgens and anabolic steroids in the treatment of cancer.
    Brodsky I
    Semin Drug Treat; 1973; 3(1):15-25. PubMed ID: 4740371
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination chemotherapy ("MABOP") in advanced refractory lymphocytic lymphoma with unfavorable histology.
    Giustolisi R; Guglielmo P; Di Raimondo F; Milone G; Cacciola E
    Haematologica; 1982 Oct; 67(5):718-24. PubMed ID: 6184271
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination of vindesine and prednisone in malignant lymphoma and acute leukemia.
    Raich PC; Walker BK; Rogers JS; Subramanian VP; Fontana JA; Knost JA; Denning B
    Cancer Treat Rep; 1983 May; 67(5):485-7. PubMed ID: 6573959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gelatinous transformation of the bone marrow as a late morphological change in imatinib mesylate treated chronic myeloid leukaemia.
    Hong FS; Mitchell CA; Zantomio D
    Pathology; 2010 Jan; 42(1):84-5. PubMed ID: 20025487
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of the MDR1 and MRP genes in patients with lymphoma with primary bone marrow involvement.
    Zenkov AN; Scvortsova NV; Chernolovskaya EL; Pospelova TI; Vlassov VV
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(6-7):843-7. PubMed ID: 15560070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose chemotherapy for non-Hodgkin lymphoma in Africa improves survival.
    McBride D
    ONS Connect; 2009 Sep; 24(9):17. PubMed ID: 19777879
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chemotherapy and immuno-chemotherapy in malignant lymphoma].
    Nishikori M; Nasu K; Shirakawa S; Karitani Y
    Rinsho Ketsueki; 1983 Apr; 24(4):320-9. PubMed ID: 6350639
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy using cytostatics. Desired and undesired effects].
    Hartwich G
    Fortschr Med; 1973 Nov; 91(31):1218-22. PubMed ID: 4751347
    [No Abstract]   [Full Text] [Related]  

  • 19. Atypical clinical presentation of visceral leishmaniasis in a patient with non-Hodgkin lymphoma.
    Cencini E; Lazzi S; Fabbri A
    Eur J Haematol; 2015 Feb; 94(2):186. PubMed ID: 24635670
    [No Abstract]   [Full Text] [Related]  

  • 20. Signet-ring cell lymphoma of bone marrow.
    Talbot DC; Davies JH; Maclennan KA; Smith IE
    J Clin Pathol; 1994 Feb; 47(2):184-6. PubMed ID: 8132840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.